773888-45-2,MFCD28385487
Catalog No.:AA00GI5Z

773888-45-2 | Biotin alkyne

Pack Size
Purity
Availability
Price(USD)
Quantity
  
500mg
98%
in stock  
$227.00   $159.00
- +
1g
98%
in stock  
$385.00   $270.00
- +
5g
98%
in stock  
$798.00   $559.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00GI5Z
Chemical Name:
Biotin alkyne
CAS Number:
773888-45-2
Molecular Formula:
C13H19N3O2S
Molecular Weight:
281.3739
MDL Number:
MFCD28385487
SMILES:
C#CCNC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1NC(=O)N2
Properties
Computed Properties
 
Complexity:
404  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
3  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
19  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0  
Rotatable Bond Count:
6  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
0.2  

Downstream Synthesis Route
773888-45-2   
4-3-4-(azidomethyl)benzoylphenyl-2-hydroxy-4-oxo-2-butenoicacidethylester 
 
(Z)-2-Hydroxy-4-oxo-4-{3-4-(4-5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno3,4-dimidazol-6-yl)-pentanoylamino-methyl}-1,2,3triazol-1-ylmethyl)-benzoyl-phenyl}-but-2-enoicacidethylester 

[1]BioorganicandMedicinalChemistry,2006,vol.14,p.7816-7825

[1]OrganicLetters,2007,vol.9,p.2131-2134

[2]Patent:WO2019/243273,2019,A1.Locationinpatent:Page/Pagecolumn98-99

[3]ChemicalCommunications,2007,p.3136-3138

[4]Patent:CN110964043,2020,A.Locationinpatent:Paragraph0052;0068-0069

[5]JournalofMedicinalChemistry,2009,vol.52,p.7003-7013

[6]JournalofMedicinalChemistry,2009,vol.52,p.6494-6498

[7]JournalofMedicinalChemistry,2022,vol.65,p.460-484

[8]JournalofNaturalProducts,2010,vol.73,p.1659-1666

[9]BioorganicandMedicinalChemistry,2006,vol.14,p.7816-7825

[10]Biomacromolecules,2012,vol.13,p.350-357

[11]Tetrahedron,2018,vol.74,p.5102-5112

[1]OrganicLetters,2007,vol.9,p.2131-2134

[2]Patent:US2016/361436,2016,A1

[3]Patent:WO2019/243273,2019,A1

[4]JournalofMedicinalChemistry,2022,vol.65,p.460-484

773888-45-2   
(Z)-2-Hydroxy-4-oxo-4-{3-4-(4-5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno3,4-dimidazol-6-yl)-pentanoylamino-methyl}-1,2,3triazol-1-ylmethyl)-benzoyl-phenyl}-but-2-enoicacid 

[1]BioorganicandMedicinalChemistry,2006,vol.14,p.7816-7825

[1]OrganicandBiomolecularChemistry,2008,vol.6,p.523-531

Literature

Title: Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-1014.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 773888-45-2
Tags:773888-45-2 Molecular Formula|773888-45-2 MDL|773888-45-2 SMILES|773888-45-2 Biotin alkyne
Catalog No.: AA00GI5Z
773888-45-2,MFCD28385487
773888-45-2 | Biotin alkyne
Pack Size: 500mg
Purity: 98%
in stock
$227.00 $159.00
Pack Size: 1g
Purity: 98%
in stock
$385.00 $270.00
Pack Size: 5g
Purity: 98%
in stock
$798.00 $559.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00GI5Z
Chemical Name: Biotin alkyne
CAS Number: 773888-45-2
Molecular Formula: C13H19N3O2S
Molecular Weight: 281.3739
MDL Number: MFCD28385487
SMILES: C#CCNC(=O)CCCC[C@@H]1SC[C@H]2[C@@H]1NC(=O)N2
Properties
Complexity: 404  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 3  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 19  
Hydrogen Bond Acceptor Count: 3  
Hydrogen Bond Donor Count: 3  
Isotope Atom Count: 0  
Rotatable Bond Count: 6  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 0.2  
Downstream Synthesis Route
773888-45-2   
4-3-4-(azidomethyl)benzoylphenyl-2-hydroxy-4-oxo-2-butenoicacidethylester 
 
(Z)-2-Hydroxy-4-oxo-4-{3-4-(4-5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno3,4-dimidazol-6-yl)-pentanoylamino-methyl}-1,2,3triazol-1-ylmethyl)-benzoyl-phenyl}-but-2-enoicacidethylester 

[1]BioorganicandMedicinalChemistry,2006,vol.14,p.7816-7825

35013-72-0    2450-71-7    773888-45-2 

[1]OrganicLetters,2007,vol.9,p.2131-2134

[2]Patent:WO2019/243273,2019,A1.Locationinpatent:Page/Pagecolumn98-99

[3]ChemicalCommunications,2007,p.3136-3138

[4]Patent:CN110964043,2020,A.Locationinpatent:Paragraph0052;0068-0069

[5]JournalofMedicinalChemistry,2009,vol.52,p.7003-7013

[6]JournalofMedicinalChemistry,2009,vol.52,p.6494-6498

[7]JournalofMedicinalChemistry,2022,vol.65,p.460-484

[8]JournalofNaturalProducts,2010,vol.73,p.1659-1666

[9]BioorganicandMedicinalChemistry,2006,vol.14,p.7816-7825

[10]Biomacromolecules,2012,vol.13,p.350-357

[11]Tetrahedron,2018,vol.74,p.5102-5112

58-85-5    773888-45-2 

[1]OrganicLetters,2007,vol.9,p.2131-2134

[2]Patent:US2016/361436,2016,A1

[3]Patent:WO2019/243273,2019,A1

[4]JournalofMedicinalChemistry,2022,vol.65,p.460-484

773888-45-2   
(Z)-2-Hydroxy-4-oxo-4-{3-4-(4-5-((3aR,6S,6aS)-2-oxo-hexahydro-thieno3,4-dimidazol-6-yl)-pentanoylamino-methyl}-1,2,3triazol-1-ylmethyl)-benzoyl-phenyl}-but-2-enoicacid 

[1]BioorganicandMedicinalChemistry,2006,vol.14,p.7816-7825

773888-45-2    1014613-76-3    1014613-81-0 

[1]OrganicandBiomolecularChemistry,2008,vol.6,p.523-531

Building Blocks More >
849767-19-7
849767-19-7
tert-Butyl 4-hydroxy-3-(hydroxymethyl)piperidine-1-carboxylate
AA00GLPN | MFCD24467008
81905-03-5
81905-03-5
2-(3-CHLOROANILINO)-4H-3,1-BENZOXAZIN-4-ONE
AA00GNDW | MFCD00262915
93000-03-4
93000-03-4
Boc-DL-Met-OH
AA00GR68 | MFCD00190811
87394-63-6
87394-63-6
1-[3-(Trifluoromethyl)pyrid-2-yl]piperazine
AA00GRH2 | MFCD00114705
903130-01-8
903130-01-8
Methyl 4-chloroquinazoline-8-carboxylate
AA00GRRF | MFCD08448164
9063-57-4
9063-57-4
TUFTSIN
AA00GRX7 | MFCD00076891
863204-01-7
863204-01-7
(2-Morpholin-4-yl-1-phenylethyl)methylamine
AA00GS5F | MFCD01862533
9013-95-0
9013-95-0
LEVAN
AA00GSFB | MFCD00131502
93546-17-9
93546-17-9
3-Chloro-1h-pyrazolo[4,3-c]pyridine-7-carbaldehyde
AA00GSO3 | MFCD05668045
91917-63-4
91917-63-4
Atrial natriuretic peptide-28 (human reduced)
AA00GSV7 | MFCD00076226
Submit
© 2017 AA BLOCKS, INC. All rights reserved.